SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-17-001895
Filing Date
2017-02-28
Accepted
2017-02-28 16:10:30
Documents
5
Effectiveness Date
2017-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 admss-82017.htm S-8 104247
2 EXHIBIT 5.1 admss-8ex51.htm EX-5.1 10033
3 EXHIBIT 23.1 admss-8ex231.htm EX-23.1 2379
4 EXHIBIT 99.5 admss-8ex995.htm EX-99.5 183937
5 cooleyl.jpg GRAPHIC 10498
  Complete submission text file 0001628280-17-001895.txt   310861
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216313 | Film No.: 17647705
SIC: 2834 Pharmaceutical Preparations